Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
The Quarterly Journal of Medicine|July 1, 1989
Clinical features of the sleep apnoea/hypopnoea syndromeK F Whyte, M B Allen, A A Jeffrey, et al.International Journal of Clinical Practice|June 1, 2005
Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart diseaseJ M Cruz-Fernández, G V Bedarida, J Adgey, et al.Cellular Immunology|November 1, 1983
Depressed natural killer cell activity in children with protein--calorie malnutrition. II. Correction of the impaired activity after nutritional recoveryL S Salimonu, E Ojo-Amaize, A O Johnson, et al.African Journal of Medicine and Medical Sciences|September 1, 1980
Conjugated hyperbilirubinaemia in Nigerian infantsA O Johnson, V A Nottidge, C O Ojo, et al.African Journal of Medicine and Medical Sciences|September 1, 1984
Range of normal serum immunoglobulin (IgG, IgA and IgM) values in NigeriansG O Oyeyinka, L S Salimonu, A I Williams, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2015
Donor Hemodynamics as a Predictor of Outcomes After Kidney Transplantation From Donors After Cardiac DeathM B Allen, E Billig, P P Reese, et al.Diabetes, Obesity & Metabolism|April 25, 2007
Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitusC Constance, S Westphal, N Chung, et al.International Journal of Clinical Practice|December 15, 2005
Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart diseaseV Barrios, N Amabile, F Paganelli, et al.International Journal of Clinical Practice|February 19, 2009
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS studyM Farnier, M Averna, L Missault, et al.Cardiology|November 20, 2008
Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary eventP Brudi, J P Reckless, D P Henry, et al.Pageof 10